{
    "nct_id": "NCT03403465",
    "official_title": "Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers ( Adaptive PET II)",
    "inclusion_criteria": "Pathologically (histologically or cytologically) proven diagnosis of cervical, vulvar, esophageal and anal canal cancer\n\nPatients with local or regional nodal disease are eligible\n\nZubrod Performance Status 0, 1, or 2\n\nAge â‰¥ 18\n\nNegative serum pregnancy test for women of child bearing potential\n\nPatient must sign study-specific informed consent prior to study entry\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "No gross disease visible on imaging at the start of radiotherapy\n\nContraindication to PET\n\nComplete response by PET achieved with pre-radiation therapy treatment (surgery or chemotherapy)\n\nBreast feeding\n\nPositive serum pregnancy test",
    "miscellaneous_criteria": ""
}